Streetbeat News

Price Targets

UTHR

Oppenheimer analyst Hartaj Singh has maintained an 'Outperform' rating on United Therapeutics and raised the price target from $575 to $600.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:08 pm

DAY

Mizuho analyst Arvind Ramnani has maintained an Outperform rating on Dayforce (NYSE:DAY) and raised the price target from $80 to $85.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:07 pm

SKY

Barclays analyst Matthew Bouley has maintained an Equal-Weight rating on Champion Homes (NYSE:SKY) and raised the price target from $85 to $90.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:05 pm

UBER

Evercore ISI Group has maintained an 'Outperform' rating on Uber Technologies and raised its price target from $90 to $120, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:05 pm

CDW

Barclays analyst Mark Moskowitz has maintained an Equal-Weight rating on CDW (NASDAQ:CDW) but has lowered the price target from $229 to $201.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:05 pm

CHRW

Barclays analyst Brandon Oglenski maintains an Underweight rating on C.H. Robinson Worldwide (NASDAQ:CHRW) but raises the price target from $75 to $85.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:03 pm

META

Susquehanna analyst Shyam Patil maintains a Positive rating on Meta Platforms and raises the price target from $600 to $675.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:02 pm

CAT

Analysts have varied opinions on Caterpillar (NYSE:CAT), with recent ratings showing a mix of bullish and bearish sentiments. The average 12-month price target has increased to $380.27, reflecting a 6.27% rise. Despite a revenue decline, Caterpillar maintains strong profitability and effective cost management.

Portfolio Pulse from Benzinga Insights

October 31, 2024 | 6:02 pm

UBER

Gordon Haskett analyst Robert Mollins has upgraded Uber Technologies from Hold to Buy, setting a price target of $85.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:02 pm

CRTO

Criteo (NASDAQ:CRTO) has received mixed analyst ratings over the past three months, with a majority being bullish. The average 12-month price target has increased by 5.51% to $54.6. Analysts have adjusted their ratings and price targets in response to market conditions, with some lowering and others maintaining or raising their targets. Criteo's financial performance shows strong net margin, ROE, and ROA, but its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

October 31, 2024 | 6:01 pm